In addition, because APS is associated with mTOR activation, further studies should focus on evaluating the role of the mTOR pathway in aPL-associated intrastent restenosis in HD patients and on assessing mTOR inhibitor-eluting balloons or stents. The gene discussed is MTOR; the disease is Huntington disease.